JP2001521547A - 脂質とラノリン誘導界面活性剤を含む水性組成物およびその使用 - Google Patents
脂質とラノリン誘導界面活性剤を含む水性組成物およびその使用Info
- Publication number
- JP2001521547A JP2001521547A JP54529698A JP54529698A JP2001521547A JP 2001521547 A JP2001521547 A JP 2001521547A JP 54529698 A JP54529698 A JP 54529698A JP 54529698 A JP54529698 A JP 54529698A JP 2001521547 A JP2001521547 A JP 2001521547A
- Authority
- JP
- Japan
- Prior art keywords
- lanolin
- composition
- composition according
- lipid
- surfactants
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/925—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of animal origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.水に加えて (a)ラノリンもしくはラノリン誘導体のポリオキシアルキレン縮合誘導体か ら選択される1以上の界面活性物質;および (b)前記1以上のラノリン誘導界面活性物質によって乳化された、約5μm 未満の平均粒子サイズを持つ粒子として存在する1以上の脂質物質を含む脂質成 分、 を含む水性組成物。 2.脂質成分がラノリンまたは1以上のラノリン誘導体を含む、請求項1に記載 の組成物。 3.脂質成分が、羊毛脂、精製ラノリン、ラノリン油、ラノリンアルコールおよ びラノリンエステルから選択される、請求項2に記載の組成物。 4.脂質成分が、ろう、長鎖炭化水素、脂肪、油、中性グリセロ脂質、極性脂質 、リン脂質、テルペン、ステロールおよびセラミド、のいずれかを含む、請求項 1に記載の組成物。 5.脂質成分の平均粒子サイズが0.01から1μmの範囲である、請求項1〜 4のいずれか一項に記載の組成物。 6.21℃で1.5から20mm2/秒の動粘性率を持つ、請求項1〜5のいず れか一項に記載の組成物。 7.組成物中の脂質成分の量が0.1から60重量%の範囲である、請求項1〜 6のいずれか一項に記載の組成物。 8.ラノリンもしくはラノリン誘導体のポリオキシアルキレン縮合誘導体が、1 以上のラノリンアルコールのポリエチレングリコールエーテル、1以上のラノリ ンアルコールのポリプロピレングリコールエーテル、1以上のラノリンのポリエ チレングリコールエーテル、および1以上のラノリン油のPPG/PEGエーテ ル、ならびにそれらの混合物、から選択される、請求項1〜7のいずれか一項に 記載の組成物。 9.基質形成剤または塗膜形成剤として働く天然由来の界面活性剤と、陰イオン 性、非イオン性、陽イオン性、双性イオン性および両性界面活性剤またはそれら の混合物から選択される合成界面活性剤のうちから選択される、1以上の補助界 面活性物質をさらに含む、請求項1〜8のいずれか一項に記載の組成物。 10.当該組成物の界面活性剤成分が、実質的にラノリンもしくはその誘導体の 1以上のポリオキシアルキレン縮合誘導体だけからなり、他の界面活性物質は実 質的に存在しない、請求項 1〜8のいずれか一項に記載の組成物。 11.組成物中の界面活性剤の総量が0.1から25重量%の範囲である、請求 項1〜10のいずれか一項に記載の組成物。 12.1以上の化粧品もしくは医薬の有効成分をさらに含む、請求項1〜11の いずれか一項に記載の組成物。 13.請求項1〜12のいずれか一項に記載の組成物を製造する方法であって、 前記1以上のラノリン誘導界面活性物質と1以上の脂質物質を一緒にして、得ら れた混合物を、前記の脂質成分の平均粒子サイズが約5μm未満になるように高 強度下で乳化させることを含んでなる方法。 14.1以上の化粧品もしくは医薬の有効成分を哺乳動物の身体に送達する方法 であって、請求項12に記載の組成物を当該身体表面の部分に適用することを含 んでなる方法。 15.当該組成物を哺乳動物の皮膚に適用する、請求項14に記載の方法。 16.1以上の化粧品もしくは医薬の有効成分を哺乳動物の身体に送達するため の担体としての、請求項1〜12のいずれか一項に記載の組成物の使用。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9708066.7A GB9708066D0 (en) | 1997-04-22 | 1997-04-22 | Compositions and their use |
GB9708066.7 | 1997-04-22 | ||
PCT/GB1998/001174 WO1998047468A1 (en) | 1997-04-22 | 1998-04-22 | Aqueous compositions comprising a lipid and a lanolin-derived surfactant, and their use |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2001521547A true JP2001521547A (ja) | 2001-11-06 |
JP4571241B2 JP4571241B2 (ja) | 2010-10-27 |
Family
ID=10811121
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP54529698A Expired - Fee Related JP4571241B2 (ja) | 1997-04-22 | 1998-04-22 | 脂質とラノリン誘導界面活性剤を含む水性組成物およびその使用 |
Country Status (11)
Country | Link |
---|---|
US (1) | US6224853B1 (ja) |
EP (1) | EP0977538B1 (ja) |
JP (1) | JP4571241B2 (ja) |
AT (1) | ATE286706T1 (ja) |
AU (1) | AU728726B2 (ja) |
CA (1) | CA2286837C (ja) |
DE (1) | DE69828596T2 (ja) |
ES (1) | ES2235327T3 (ja) |
GB (2) | GB9708066D0 (ja) |
NZ (1) | NZ500509A (ja) |
WO (1) | WO1998047468A1 (ja) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0022337D0 (en) * | 2000-09-12 | 2000-10-25 | Barrier Biotech Ltd | An antimicrobial composition |
US20040151765A1 (en) * | 2001-09-18 | 2004-08-05 | Ritchie Branson W. | Methods and compositions for wound management |
US20040208842A1 (en) * | 2001-09-18 | 2004-10-21 | Ritchie Branson W. | Antimicrobial cleansing compositions and methods of use |
US20070003508A1 (en) * | 2005-07-01 | 2007-01-04 | Wooley Richard E | Methods and compositions for promoting wound healing |
US7763663B2 (en) * | 2001-12-19 | 2010-07-27 | University Of Massachusetts | Polysaccharide-containing block copolymer particles and uses thereof |
CN101889981A (zh) * | 2003-11-20 | 2010-11-24 | Ym生物科学有限公司 | 包含含有药物成分的亲脂胺的稳定脂质体组合物 |
WO2005091967A2 (en) * | 2004-03-03 | 2005-10-06 | University Of Georgia Research Foundation, Inc. | Methods and compositions for ophthalmic treatment of fungal and bacterial infections |
WO2006079830A1 (en) * | 2005-01-29 | 2006-08-03 | Croda International Plc | Alkoxylated lanolin derivatives and compositions therewith |
CN101384247B (zh) | 2005-07-18 | 2013-05-22 | 麻萨诸塞州洛厄尔大学 | 制备与使用纳米乳剂的组合物和方法 |
US9486408B2 (en) | 2005-12-01 | 2016-11-08 | University Of Massachusetts Lowell | Botulinum nanoemulsions |
DK3295955T3 (da) | 2005-12-01 | 2021-07-05 | Univ Massachusetts Lowell | Botulinum nanoemulsioner |
CN101848702B (zh) | 2006-12-01 | 2013-07-17 | 安特里奥公司 | 两亲实体纳米粒子 |
US20100172943A1 (en) | 2006-12-01 | 2010-07-08 | Anterios, Inc. | Peptide nanoparticles and uses therefor |
EP2162117B1 (en) | 2007-05-31 | 2018-02-21 | Anterios, Inc. | Nucleic acid nanoparticles and uses therefor |
US20110223204A1 (en) * | 2008-06-04 | 2011-09-15 | Bradford J Duft | Treatment of pain with gap junction modulation compounds |
US20110212157A1 (en) * | 2008-06-26 | 2011-09-01 | Anterios, Inc. | Dermal delivery |
WO2013110077A1 (en) | 2012-01-19 | 2013-07-25 | Hybrid Medical, Llc | Topical therapeutic formulations |
CA2868534A1 (en) | 2012-03-27 | 2013-10-03 | Coda Therapeutics, Inc. | Compositions and treatments based on cadherin modulation |
NZ701949A (en) | 2012-05-18 | 2016-07-29 | Otago Innovation Ltd | Combination treatments and compositions for wound healing |
US20150182451A1 (en) * | 2013-12-27 | 2015-07-02 | The Dial Corporation | Cleansing composition for hormone deposition |
BR112019010131A2 (pt) | 2016-11-21 | 2019-10-08 | Eirion Therapeutics Inc | entrega transdérmica de agentes grandes |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3666857A (en) * | 1966-03-04 | 1972-05-30 | Malmstrom Chem Corp | Aqueous compositions containing lanolin oil |
JPS5729213B2 (ja) | 1974-11-12 | 1982-06-21 | ||
US5489426A (en) * | 1980-07-01 | 1996-02-06 | L'oreal | Cosmetic composition based on an aqueous dispersion of small lipid spheres |
US5439672A (en) * | 1980-07-01 | 1995-08-08 | L'oreal | Cosmetic composition based on an aqueous dispersion of small lipid spheres |
DE3161962D1 (en) * | 1980-07-01 | 1984-02-23 | Oreal | Process for obtaining stable dispersions in an aqueous phase of at least a water immiscible liquid phase, and corresponding dispersions |
DE3338890A1 (de) * | 1983-10-27 | 1985-05-09 | Beiersdorf Ag, 2000 Hamburg | Neue o/w-emulgatoren fuer kosmetische zwecke |
DE68917544T2 (de) | 1988-06-20 | 1994-12-15 | Shiseido Co Ltd | Durchsichtiges Präparat. |
HU212924B (en) | 1989-05-25 | 1996-12-30 | Chiron Corp | Adjuvant formulation comprising a submicron oil droplet emulsion |
GB2297762A (en) * | 1994-12-05 | 1996-08-14 | Procter & Gamble | Personal cleaning compositions |
-
1997
- 1997-04-22 GB GBGB9708066.7A patent/GB9708066D0/en active Pending
-
1998
- 1998-04-22 JP JP54529698A patent/JP4571241B2/ja not_active Expired - Fee Related
- 1998-04-22 GB GB9913095A patent/GB2334446B/en not_active Expired - Fee Related
- 1998-04-22 ES ES98917438T patent/ES2235327T3/es not_active Expired - Lifetime
- 1998-04-22 US US09/403,526 patent/US6224853B1/en not_active Expired - Fee Related
- 1998-04-22 NZ NZ500509A patent/NZ500509A/en not_active IP Right Cessation
- 1998-04-22 AT AT98917438T patent/ATE286706T1/de not_active IP Right Cessation
- 1998-04-22 WO PCT/GB1998/001174 patent/WO1998047468A1/en active IP Right Grant
- 1998-04-22 DE DE69828596T patent/DE69828596T2/de not_active Expired - Lifetime
- 1998-04-22 AU AU70667/98A patent/AU728726B2/en not_active Ceased
- 1998-04-22 CA CA2286837A patent/CA2286837C/en not_active Expired - Fee Related
- 1998-04-22 EP EP98917438A patent/EP0977538B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE69828596T2 (de) | 2005-12-01 |
GB2334446A (en) | 1999-08-25 |
CA2286837A1 (en) | 1998-10-29 |
EP0977538A1 (en) | 2000-02-09 |
AU7066798A (en) | 1998-11-13 |
US6224853B1 (en) | 2001-05-01 |
GB2334446B (en) | 2002-01-09 |
WO1998047468A1 (en) | 1998-10-29 |
CA2286837C (en) | 2010-10-19 |
DE69828596D1 (de) | 2005-02-17 |
ATE286706T1 (de) | 2005-01-15 |
GB9913095D0 (en) | 1999-08-04 |
AU728726B2 (en) | 2001-01-18 |
JP4571241B2 (ja) | 2010-10-27 |
EP0977538B1 (en) | 2005-01-12 |
ES2235327T3 (es) | 2005-07-01 |
NZ500509A (en) | 2004-01-30 |
GB9708066D0 (en) | 1997-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4571241B2 (ja) | 脂質とラノリン誘導界面活性剤を含む水性組成物およびその使用 | |
FI108277B (fi) | Topikaalinen valmiste, joka sisältää kiinteiden lipidipartikkeleiden suspension | |
US4670185A (en) | Aqueous vesicle dispersion having surface charge | |
US5137725A (en) | Dispersion of lipidic spherules | |
KR100369258B1 (ko) | 옥시에틸렌화 또는 비-옥시에틸렌화 소르비탄지방에스테르 기재 나노에멀젼, 및 화장, 피부학 및/또는안과학 분야에서의 그의 용도 | |
KR100369260B1 (ko) | 알킬에테르시트레이트 기재 나노에멀젼, 및 화장, 피부학,약학 및/또는 안과학 분야에서의 그의 용도 | |
CA2790154C (en) | Foam formulations containing at least one triterpenoid | |
NZ200232A (en) | Skin-penetrating pharmaceutical composition in the form of as microemulsion | |
KR101642054B1 (ko) | 경피 전달용 조성물 및 이를 함유하는 화장품 | |
US10561627B2 (en) | Ibuprofen nanoparticle carriers encapsulated with hermetic surfactant films | |
US20090232881A1 (en) | Enhanced Delivery of Skin Benefit Agents | |
CA3147460C (en) | Insoluble active substance carrier comprising transfersome | |
US10596117B1 (en) | Lipoleosomes as carriers for aromatic amide anesthetic compounds | |
AU764483B2 (en) | Aqueous compositions comprising a lipid and a lanolin-derived surfactant, and their use | |
AU7155891A (en) | Pharmaceutical formulation | |
JPH0366618A (ja) | 薬学的配合物 | |
US11007161B1 (en) | Ibuprofen nanoparticle carriers encapsulated with hermatic surfactant films | |
EP4112044A1 (en) | Composition for particle-mediated transport of a dissolved active agent into hair follicles | |
JPH10236920A (ja) | 乳化組成物 | |
JPH02290818A (ja) | 癒合助長用組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20041109 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20041029 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20050202 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20050318 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050509 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20060131 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060530 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20060615 |
|
A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20060928 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080526 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080529 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090714 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090730 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090810 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090819 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091013 |
|
RD13 | Notification of appointment of power of sub attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7433 Effective date: 20100506 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100623 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20100812 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130820 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
LAPS | Cancellation because of no payment of annual fees |